Clinical Trial Update: KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing telithromycin to azithromycin in outpatients with community-acquired lower respiratory tract infections has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Pneumonia

Drugs mentioned

• Ketek (telithromycin)
• ZITHROMAX (AZITHROMYCIN DIHYDRATE)

Snippet

Sponsor: Sanofi | Conditions: Respiratory Tract Infections, Chronic Bronchitis | Phase 4 | Status: TERMINATED